Difference between revisions of "Template:Antiemetics"
Jump to navigation
Jump to search
blackwiki>Anypodetos |
blackwiki>Anypodetos m (Remove caps per MOS:CAPS; minor fixes) |
||
Line 6: | Line 6: | ||
|listclass = hlist | |listclass = hlist | ||
− | | group1 = [[5-HT3 antagonist|5- | + | | group1 = [[5-HT3 antagonist|5-HT<sub>3</sub> serotonin ion<br/> channel antagonist]]s |
| list1 = | | list1 = | ||
* [[Alosetron]] | * [[Alosetron]] | ||
Line 29: | Line 29: | ||
* [[Zatosetron]] | * [[Zatosetron]] | ||
− | | group2 = [[Serotonin antagonist|5-HT | + | | group2 = [[Serotonin antagonist|5-HT serotonin G-protein<br/> receptor antagonist]]s |
| list2 = | | list2 = | ||
* [[Clozapine]] | * [[Clozapine]] | ||
Line 38: | Line 38: | ||
* [[Ziprasidone]] | * [[Ziprasidone]] | ||
− | | group3 = [[CB1 receptor|CB<sub>1</sub>]] [[ | + | | group3 = [[CB1 receptor|CB<sub>1</sub>]] [[agonist]]s<br/> ([[cannabinoid]]s) |
| list3 = | | list3 = | ||
* [[Dronabinol]] | * [[Dronabinol]] | ||
Line 44: | Line 44: | ||
* [[Tetrahydrocannabinol]] ([[cannabis (drug)|cannabis]]) | * [[Tetrahydrocannabinol]] ([[cannabis (drug)|cannabis]]) | ||
− | | group4 = [[Dopamine antagonist|D<sub>2</sub>/D<sub>3</sub> | + | | group4 = [[Dopamine antagonist|D<sub>2</sub>/D<sub>3</sub> antagonist]]s |
| list4 = | | list4 = | ||
* [[Alizapride]] | * [[Alizapride]] | ||
Line 59: | Line 59: | ||
* [[Thiethylperazine]] | * [[Thiethylperazine]] | ||
− | | group5 = [[H1 antagonist|H<sub>1</sub> antagonists]] <br/>([[Histamine antagonist| | + | | group5 = [[H1 antagonist|H<sub>1</sub> antagonists]] <br/>([[Histamine antagonist|antihistamines]]) |
| list5 = | | list5 = | ||
* [[Cyclizine]] | * [[Cyclizine]] | ||
Line 68: | Line 68: | ||
* [[Promethazine]] | * [[Promethazine]] | ||
− | | group6 = [[Muscarinic acetylcholine receptor|mACh]] [[Receptor_Antagonist|antagonists]]<br/> ([[ | + | | group6 = [[Muscarinic acetylcholine receptor|mACh]] [[Receptor_Antagonist|antagonists]]<br/> ([[anticholinergic]]s) |
| list6 = | | list6 = | ||
* [[Atropine]] | * [[Atropine]] | ||
Line 76: | Line 76: | ||
* [[Hyoscine hydrobromide|Scopolamine]] | * [[Hyoscine hydrobromide|Scopolamine]] | ||
− | | group7 = [[NK1 receptor antagonist|NK<sub>1</sub> | + | | group7 = [[NK1 receptor antagonist|NK<sub>1</sub> antagonists]] |
| list7 = | | list7 = | ||
* [[Aprepitant]] | * [[Aprepitant]] | ||
Line 99: | Line 99: | ||
{{collapsible option}} | {{collapsible option}} | ||
[[Category:Antiemetics]] | [[Category:Antiemetics]] | ||
− | [[Category: | + | [[Category:Drug templates by ATC]] |
</noinclude> | </noinclude> |
Revision as of 11:23, 15 July 2016
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state=
parameter may be used:
|state=collapsed
:{{Antiemetics|state=collapsed}}
to show the template collapsed, i.e., hidden apart from its title bar|state=expanded
:{{Antiemetics|state=expanded}}
to show the template expanded, i.e., fully visible|state=autocollapse
:{{Antiemetics|state=autocollapse}}
If the |state=
parameter in the template on this page is not set, the template's initial visibility is taken from the |default=
parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse
.